Recombinant Timothy grass pollen allergoids (Allergopharma)

N/A

Report date: 2022/07/26 20:00:33

Base Information

Drug NameRecombinant Timothy grass pollen allergoids (Allergopharma)
Drug Alias NameHigh-dose rPhleum重组猫尾草花粉类变应原 - AllergopharmarPhleum
ClassificationBiologics > Antigen > Allergen extract
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHypersensitivity, ImmediateHypersensitivityConjunctivitis, Allergic +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaGermany
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiomay Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergopharma Gmbh & Co Kg
Active IndicationsN/A
Inactive IndicationsHypersensitivity, ImmediateHypersensitivityConjunctivitis, Allergic +[5] 

Other Information

ATC CodeN/A
Related LinksN/A